Baird Starts Medpace (MEDP) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
William Blair Starts Medpace (MEDP) at Outperform
September 6, 2016 8:02 AM EDTWilliam Blair initiated coverage on Medpace (NASDAQ: MEDP) with an Outperform rating.
For an analyst ratings summary and ratings history on Medpace click here. For more ratings news on Medpace click here.
Shares of Medpace closed at $30.70 yesterday.
... MoreCredit Suisse Starts Medpace (MEDP) at Outperform
September 6, 2016 7:08 AM EDTCredit Suisse initiates coverage on Medpace (NASDAQ: MEDP) with a Outperform rating and a price target of $35.00.
Analyst Erin Wilson commented, "MEDP is a leading global clinical stage contract research organization (CRO), differentiated in its exclusively full-service model. It should benefit from a... More
Wells Fargo Starts Medpace (MEDP) at Outperform
September 6, 2016 6:55 AM EDTWells Fargo initiated coverage on Medpace (NASDAQ: MEDP) with an Outperform rating.
For an analyst ratings summary and ratings history on Medpace click here. For more ratings news on Medpace click here.
Shares of Medpace closed at $30.70 yesterday.
... MoreJefferies Starts Medpace (MEDP) at Hold
September 6, 2016 6:46 AM EDTJefferies initiates coverage on Medpace (NASDAQ: MEDP) with a Hold rating and a price target of $32.50.
Analyst David Windley commented, "We initiate on MEDP with a $32.50 PT and Hold rating on valuation (+33.5% since pricing). MEDP competes in the phase I-IV CRO space, wins mandates... More
UBS Starts Medpace (MEDP) at Buy
September 6, 2016 6:42 AM EDTUBS initiated coverage on Medpace (NASDAQ: MEDP) with a Buy rating and a price target of $35.00.
For an analyst ratings summary and ratings history on Medpace click here. For more ratings news on Medpace click here.
Shares of Medpace closed at $30.70 yesterday.
... More